Section 5925 - Lead poisoning prevention, assessment and testing(a)Lead testing for children.-- (1) The following:(i) A health care provider shall consider possible lead exposure in an individual patient by evaluating risk factors for lead exposure and perform blood lead testing in accordance with recommendations from the Centers for Disease Control and Prevention and the American Academy of Pediatrics by 24 months of age. (ii) If a patient has never been tested in accordance with recommendations from the Centers for Disease Control and prevention and the American Academy of Pediatrics by 24 months of age, a health care provider shall consider possible lead exposure and perform blood lead testing in an individual patient between 24 months and 72 months of age.(iii) A health care provider shall make reasonable efforts to ensure that a patient's parent or legal guardian understands the risks and benefits of blood lead testing prior to obtaining consent.(2) If a patient's parent or legal guardian consents to blood lead testing for the patient under paragraph (1) and the results of a capillary blood lead test indicate an elevated blood lead level, the health care provider shall perform a confirmatory blood lead test by venipuncture within 12 weeks of the first blood lead test test after obtaining the consent of the patient's parent or legal guardian.(b)Lead exposure risk assessment and testing requirements for pregnant women.--A health care provider shall consider possible lead exposure in individual pregnant women by evaluating risk factors for lead exposure and perform blood lead testing if a single risk factor is identified in accordance with recommendations from the Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists.(c) Reporting.--Health care providers and laboratories shall comply with reporting regulations as specified in 28 Pa. Code § 27.34 (relating to reporting cases of lead poisoning). Added by P.L. TBD 2022 No. 150, § 5, eff. 1/3/2023.